STARTDublin 👍👍👍

Great to have our Assistant Director of Nursing Ciara Clancy presenting on START at the ANP & CNS Grand Rounds this morning. The START Center

We're proud to share that START has achieved a significant milestone: the first patient has been dosed in #NiKangTherapeutics Inc.'s Phase 1/1b clinical trial of NKT3447 at START Mountain Region, led by our very own Dr. Justin Call and Dr. William McKean. businesswire.com/news/home/2024…

Delighted to be asked to speak at the HRB NCTO International Clinical Trials Day yesterday to spread the word of STARTDublin. The first dedicated early phase centre in the Republic of Ireland, bringing cutting edge research to Irish patients. The START Center Mater Hospital Advanced Cancer Care

Excited to announce our partnership with Northwell Health’s Cancer Institute to bring early-phase cancer #clinicaltrials to NY's diverse patient population! Read more about our new partnership: startresearch.com/northwell-heal…

Exciting announcement for the START network! Together we aim to bring phase I clinical trials to every and any patient who needs them globally. The START Center

Great to see the START family get bigger- welcome Northwell Health

Persona narrator and the doctor-writer - The Lancet thelancet.com/journals/lance…

So great to meet up with the rest of the START family at ASCO. Exciting times ahead and hope to be treating patients very soon in Dublin

Register today for our upcoming webinar on “Enhancing CDK 4/6 Inhibitor Efficacy in Advanced #BreastCancer” - July 9 at 3pm ET. Presented by our CSO, Dr. Michael J Wick events.zoom.us/ev/Aoxc2fPSNOk…

#DYK cancer vaccines could transform the management of cancer? Speaking with Medical Independent Priscilla Lynch, #OurMaterTeam STARTDublin consultant oncologist Austin Duffy described such vaccines as “the ultimate in personalised medicine.” medicalindependent.ie/in-the-news/ne…

The long awaited botensilimab/balstilimab advanced line CRC study is published. Congrats Ben Schlechter! nature.com/articles/s4159…

Have you seen the latest feature in Health Tech World? Drs. Calvo & Victor Moreno of START featured & sharing insights on Spain's growth in oncology, patient access to clinical trials, and developments in personalized medicine 👏

Proud to share our team has dosed all three patients in the first cohort of the LOXO-FRA-24001 (J5E-OX-JZXA) trial. This study, in collaboration with Loxo@Lilly Oncology Medical, evaluates an #ADC targeting folate receptor alpha with a topoisomerase 1 inhibitor payload.

Ireland is now the world’s third-largest exporter of pharmaceuticals, and the industry is the greatest single source of national income, but Irish patients can not access cutting-edge treatments. Paul McAuliffe TD Stephen Donnelly Róisín Shortall extra.ie/2024/08/18/new…

START is proud to have dosed the first patient in the MOMA-313 Phase 1 trial, a novel therapy targeting polymerase theta for homologous recombination-deficient cancers. Grateful for our partnership with MOMA Therapeutics and the potential impact on patients!

🤩We are proud to share that Amita Patnaik The START Center has dosed the 1st patient with MOMA Therapeutics MOMA-313 - a highly potent & selective small molecule inhibitor of polymerase theta, an innovative therapeutic approach for patients with HRD-cancers‼️ bit.ly/4cEbqSd

Now Live!!! START’s Virtual Panel Series featuring the hottest topics in oncology clinical research. Join us for our conversations on ADCs, malignant hematology, precision medicine, monoclonal antibodies, and more! startresearch.com/start-announce…